the PNF has been investigating the pharmaceutical giant since March for suspicions of “price manipulation”

The National Financial Prosecutor’s Office opened an investigation last March for “dissemination of false or misleading information” and “price manipulation” against the French pharmaceutical giant Sanofi, franceinfo learned on Tuesday, November 7 from a judicial source, confirming information from The letter.

This preliminary investigation was entrusted to the financial brigade, this source told franceinfo, explaining that it concerns the financial communication of the Sanofi group.

Questioned by AFP, Sanofi claims not to be “aware of any preliminary investigation by the National Financial Prosecutor’s Office into its 2017 accounts or otherwise” And “reserves the right to take legal action against any false or defamatory allegations”. “As a listed company, the financial information that Sanofi publishes is accurate, precise and sincere, and is also duly audited by two auditing firms”assures the group in a written reaction sent to AFP.